Stockholders' Equity | 6. Stockholders’ Equity Common Stock During the three months ended March 31, 2024 and 2023 , the Company issued 100,417 and 108,404 shares, respectively, of common stock pursuant to its long-term incentive plan (see “Long Term Incentive Plan” below). As of March 31, 2024, the Company had 25,774,730 shares of common stock, par value $ 0.01 per share, issued and outstanding. Share Repurchase Program On June 15, 2016, the Board authorized the Company to repurchase up to $ 30.0 million of its common stock, par value $ 0.01 per share, during a two-year period that was set to expire on June 15, 2018 (the “Share Repurchase Program”). On April 30, 2018, the Board increased the Share Repurchase Program from $ 30.0 million to up to $ 40.0 million and extended it by an additional two years to June 15, 2020 . On March 13, 2020, the Board further increased the Share Repurchase Program from $ 40.0 million to up to $ 100.0 million and extended it to March 12, 2023 . On October 24, 2022, the Board authorized the Company to repurchase an indeterminate number of shares of our common stock at an aggregate market value of up to $ 100.0 million during a two-year period that will expire on October 24, 2024 . This authorization replaced the Board's prior authorization. The Company may utilize various methods to affect the repurchases, and the timing and extent of the repurchases will depend upon several factors, including market and business conditions, regulatory requirements and other corporate considerations, including whether the Company’s common stock is trading at a significant discount to net asset value per share. Repurchases under this program may be discontinued at any time. During the three months ended March 31, 2024 and 2023 , the Company did no t make any share repurchases. Since the inception of the Share Repurchase Program through March 31, 2024, the Company has repurchased 2,550,628 shares of its common stock, par value $ 0.01 per share, at a total cost of approximately $ 72.4 million, or $ 28.36 per share on average. Restricted Stock Units Under the Company’s 2016 Long Term Incentive Plan (the "2016 LTIP"), restricted stock units may be granted to the Company’s directors, officers and other key employees (and those of the Adviser and the Company’s subsidiaries) and typically vest over a three to five-year period for officers, employees and certain key employees of the Adviser and annually for directors. Beginning on the date of grant, restricted stock units earn dividends that are payable in cash on the vesting date. The following table includes the number of restricted stock units granted to its directors, officers, employees and certain key employees of the Adviser under the 2016 LTIP: Summary of Grants February March May Total 2019 186,662 — — 186,662 2020 168,183 — 116,852 285,035 2021 204,663 — — 204,663 2022 142,519 — — 142,519 2023 — 260,709 — 260,709 2024 — 355,475 — 355,475 Total 702,027 616,184 116,852 1,435,063 As of March 31, 2024 and December 31, 2023 , the Company had 780,599 and 620,137 unvested units under the 2016 LTIP, respectively. The following table includes the number of restricted stock units granted, vested, forfeited and outstanding as of March 31, 2024: 2024 Number of Units Weighted Average Outstanding January 1, 620,137 $ 47.50 Granted 355,475 30.89 Vested ( 195,013 ) (1) 47.00 Forfeited — — Outstanding March 31, 780,599 $ 40.19 (1) Certain key employees of the Adviser elected to net the taxes owed upon vesting against the shares issued resulting in 100,417 shares being issued as shown on the Consolidated Statement of Stockholders’ Equity. During the three months ended March 31, 2024, 50,201 shares vested under the 2016 LTIP that had not settled as of March 31, 2024. The following table contains information regarding the vesting of restricted stock units under the 2016 LTIP for the next five calendar years subsequent to March 31, 2024: Shares Vesting February March May June Total 2024 — — 21,877 841 22,718 2025 97,154 136,671 21,769 — 255,594 2026 64,147 114,965 — — 179,112 2027 26,281 114,965 — — 141,246 2028 — 114,958 — — 114,958 2029 — 66,971 — — 66,971 Total 187,582 548,530 43,646 841 780,599 As of March 31, 2024 and December 31, 2023, the Company had issued 1,132,822 and 982,204 shares of common stock under the 2016 LTIP, respectively. For the three months ended March 31, 2024 and 2023, the Company recognized approximately $ 2.5 million and $ 2.0 million , respectively, of equity-based compensation expense related to grants of restricted stock units. For the three months ended March 31, 2024 and 2023, the Company recognized approximately $ 2.5 million and $ 2.0 million , respectively, of equity-based compensation expense related to grants of restricted stock units. As of March 31, 2024 and December 31, 2023, the Company had recognized a liability of approximately $ 1.6 million and $ 2.1 million, respectively, related to dividends earned on restricted stock units that are payable in cash upon vesting which is included in accounts payable and other accrued liabilities on the consolidated balance sheets. Forfeitures are recognized as they occur. As of March 31, 2024 and December 31, 2023 . the Company had total unrecognized compensation expense on restricted awards of approximately $ 30.0 million and $ 21.5 million over a weighted average vesting period of 2.3 and 1.5 years, respectively. At-the-Market Offering On March 4, 2020, the Company, the OP and the Adviser entered into separate equity distribution agreements with each of Jefferies LLC (“Jefferies”), Raymond James & Associates, Inc. (“Raymond James”), KeyBanc Capital Markets Inc. (“KeyBanc”) and Truist Securities (f/k/a SunTrust Robinson Humphrey, Inc., “SunTrust,” and together with Jefferies, Raymond James and KeyBanc, the “ATM Sales Agents”), pursuant to which the Company could issue and sell from time to time when an effective registration statement was available shares of the Company’s common stock, par value $ 0.01 per share, having an aggregate sales price of up to $ 225,000,000 (the “2020 ATM Program”). Sales of shares of common stock, if any, could be made in transactions that were deemed to be “at the market” offerings, as defined in Rule 415 under the Securities Act, including, without limitation, sales made by means of ordinary brokers’ transactions on the New York Stock Exchange, to or through a market maker at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices based on prevailing market prices. In addition to the issuance and sale of shares of common stock, the Company could enter into forward sale agreements with each of Jefferies, KeyBanc and Raymond James, or their respective affiliates, through the 2020 ATM Program. During the three months ended March 31, 2024 and 2023 , no shares were issued under the 2020 ATM Program. The following table contains summary information of the 2020 ATM Program since its inception: Gross proceeds $ 62,310,967 Common shares issued 1,120,910 Gross average sale price per share $ 55.59 Sales commissions $ 934,665 Offering costs 1,353,015 Net proceeds 60,023,287 Average price per share, net $ 53.55 |